Generex Biotechnology Corporation
GNBT · OTC
4/30/2021 | 1/31/2021 | 10/31/2020 | 7/31/2020 | |
|---|---|---|---|---|
| Market Cap | $6,418 | $6,167 | $5,424 | $4,311 |
| - Cash | $1,675 | $596 | $834 | $15 |
| + Debt | $9,288 | $10,766 | $10,510 | $11,234 |
| Enterprise Value | $14,031 | $16,336 | $15,101 | $15,530 |
| Revenue | $21 | $0 | $88 | $584 |
| % Growth | – | -100% | -84.8% | – |
| Gross Profit | -$45 | -$105 | $65 | $419 |
| % Margin | -218.9% | – | 73.6% | 71.9% |
| EBITDA | $9,817 | -$23,537 | -$9,692 | -$9,905 |
| % Margin | 47,438.5% | – | -10,959.1% | -1,697.2% |
| Net Income | $9,223 | -$326 | -$258 | -$12,570 |
| % Margin | 44,566.3% | – | -291.7% | -2,153.8% |
| EPS Diluted | 0.066 | -0.22 | -0.11 | -0.15 |
| % Growth | 129.9% | -100% | 26.7% | – |
| Operating Cash Flow | $577 | -$980 | -$1,336 | -$634 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $577 | -$980 | -$1,336 | -$634 |